FDA keeps the new devices coming

As the FDA grapples with a once-in-a-generation crisis and tries to speed drugs, vaccines, devices and diagnostics to market, the less pressing business of evaluating and approving non-Covid-19-related medical technologies has taken a back seat. Even so, the number of devices approved by the agency has not dipped as much as might have been feared.